Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy

JC Arroyave-Ospina, Z Wu, Y Geng, H Moshage - Antioxidants, 2021 - mdpi.com
Oxidative stress (OxS) is considered a major factor in the pathophysiology of inflammatory
chronic liver diseases, including non-alcoholic liver disease (NAFLD). Chronic impairment of …

Vitamin E: Emerging aspects and new directions

F Galli, A Azzi, M Birringer, JM Cook-Mills… - Free Radical Biology …, 2017 - Elsevier
The discovery of vitamin E will have its 100th anniversary in 2022, but we still have more
questions than answers regarding the biological functions and the essentiality of vitamin E …

New insights into the pathogenesis of non-alcoholic fatty liver disease: gut-derived lipopolysaccharides and oxidative stress

D Ferro, F Baratta, D Pastori, N Cocomello, A Colantoni… - Nutrients, 2020 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. The intricate NAFLD pathogenesis is summarized by the multiple-hits …

Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study

F Baratta, D Pastori, F Angelico, A Balla… - Clinical …, 2020 - Elsevier
Background & Aims Patients with non-alcoholic fatty liver disease (NAFLD) are at increased
chance for cardiovascular events (CVEs). Severity of liver fibrosis is used to determine …

[HTML][HTML] The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review

JF Dufour, R Scherer, MM Balp, SJ McKenna… - … and Metabolic Science, 2021 - Elsevier
Background There is a wide variation across studies in the reported prevalence of
nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). A …

Oxidative stress in non-alcoholic fatty liver disease

C Smirne, E Croce, D Di Benedetto, V Cantaluppi… - Livers, 2022 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it still remains an orphan of adequate therapies. This …

The role of nutraceuticals for the treatment of non‐alcoholic fatty liver disease

M Del Ben, L Polimeni, F Baratta… - British journal of …, 2017 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) represents the most common chronic liver
disease. It is characterized by a wide spectrum of hepatic changes, which may progress to …

Alternative treatment methods attenuate the development of NAFLD: A review of resveratrol molecular mechanisms and clinical trials

T Charytoniuk, K Drygalski… - Nutrition, 2017 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is considered to be one of the most common liver
pathologies that occur widely among societies with a predominance of the Western dietary …

Rising influence of nanotechnology in addressing oxidative stress-related liver disorders

S Padmanaban, D Pully, AV Samrot, V Gosu… - Antioxidants, 2023 - mdpi.com
Reactive oxygen species (ROS) play a significant role in the survival and decline of various
biological systems. In liver-related metabolic disorders such as steatohepatitis, ROS can act …

Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease

D Pastori, F Baratta, M Novo, N Cocomello… - Journal of Clinical …, 2018 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is characterized by an atherogenic dyslipidaemia
and an increased cardiovascular risk. Remnant lipoprotein cholesterol (RLP-C) is emerging …